Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Oncologist|February 15, 2026
A prospective external validation of the GRade, Age, Nodes and Tumor (GRANT) score in the ECOG-ACRIN EA8143 PROSPER trialSebastiano Buti, Se-Eun Kim, Michele Maffezzoli, et al.
The Oncologist|July 28, 2025
Global Variations in Oncology Professionals' Confidence Levels for Managing Antibody-Drug Conjugate Toxicities: A Cross-Continental SurveyMarina Campione, Michele Maffezzoli, Aruni Ghose, et al.
Cancer Treatment and Research Communications|May 10, 2025
The prognostic value of the haemoglobin/red cell distribution width ratio in a cohort of pre-treated patients with renal cell carcinoma receiving nivolumabGiulia Claire Giudice, Sara Elena Rebuzzi, Giulia Mazzaschi, et al.
Immunotherapy|August 6, 2024
Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapyFabiana Perrone, Federica Pecci, Michele Maffezzoli, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 11, 2024
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint InhibitorsGiulia Mazzaschi, Fabiana Perrone, Giuseppe Maglietta, et al.
Chinese Clinical Oncology|September 2, 2025
New hormonal agents and integrated strategies for non-metastatic, hormone-sensitive prostate carcinoma: the orphan setting?-a narrative reviewFabrizio Di Costanzo, Iolanda Santa Parisi, Giuseppe Neola, et al.
Tumori|May 4, 2026
International multicenter experience of prognostic factors and treatment outcomes of metastatic non-clear cell renal cell carcinomaAlessandro Rametta, Sebastiano Buti, Marco Stellato, et al.
Clinical Genitourinary Cancer|April 17, 2024
Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27Marco Stellato, Sebastiano Buti, Marco Maruzzo, et al.
The Oncologist|July 3, 2026
The Impact of Relative Dose Intensity on pCR in Neoadjuvant Chemotherapy of Muscle-Invasive Urothelial Cancer: a Multicentre Retrospective StudyGiuseppe Neola, Fabiano Flauto, Carmine Caso, et al.
Clinical & Experimental Metastasis|February 16, 2024
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinationsMichele Maffezzoli, Matteo Santoni, Giulia Mazzaschi, et al.
Pageof 3